US Patent 11174252 Heterocyclic compounds as kinase inhibitors
Patent 11174252 was granted and assigned to Nuvation Bio on November, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11174252 Heterocyclic compounds as kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
